Time Factor in Radiotherapy and Chemotherapy for Limited Disease Small-Cell Lung Cancer

By Nowara Elzbieta   Suwinski Rafal  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Mid-course thoracic radiotherapy with cisplatin-etoposide chemotherapy in limited-stage small-cell lung cancer

By Akyurek Serap   Onal Cem   Cagar Aysun   Hicsonmez Ayse   Andrieu Meltem   Kurtman Cengiz  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 499-505

Humana Press, Inc

Access to resources Recommend Favorite

Efficacy of chemotherapy in limited-disease small-cell lung cancer

By Kenmotsu Hirotsugu  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 483-492

Future Medicine

Access to resources Recommend Favorite

Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.

By Hallqvist Andreas   Rylander Hillevi   Björk-Eriksson Thomas   Nyman Jan  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 969-974

Informa Healthcare

Access to resources Recommend Favorite

Rapidly Alternating Combination of Cisplatin-based Chemotherapy and Hyperfractionated Accelerated Radiotherapy in Split Course for Stage IIIA and Stage IIIB Non-small Cell Lung Cancer: Results of a Phase I-II Study by the GOTHA Group

By Alberto P.   Mirimanoff R.O.   Mermillod B.   Leyvraz S.   Nagy-Mignotte H.   Bolla M.   Wellmann D.   Moro D.   Brambilla E.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 342-348

Elsevier

Access to resources Recommend Favorite